Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd
301130
Company Profile
Business description
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.
Contact
No. 777, Xidian Street
Panshi Economic Development Zone
Jilin Province
Panshi132300
CHNT: +86 43265888277
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
313
Stocks News & Analysis
stocks
Cheap e-commerce share continues sales momentum
The e-commerce business continues its sales momentum despite challenging backdrop.
stocks
Chart of the Week: Booming mined commodity prices see little value on offer
Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,798.80 | 85.90 | -0.97% |
| CAC 40 | 8,207.89 | 34.78 | 0.43% |
| DAX 40 | 25,177.80 | 7.09 | -0.03% |
| Dow JONES (US) | 50,644.28 | 182.60 | 0.36% |
| FTSE 100 | 10,505.01 | 13.62 | 0.13% |
| HKSE | 24,740.39 | 587.84 | -2.32% |
| NASDAQ | 26,674.73 | 18.55 | 0.07% |
| Nikkei 225 | 63,988.99 | 1,010.42 | -1.55% |
| NZX 50 Index | 13,203.65 | 24.16 | -0.18% |
| S&P 500 | 7,520.36 | 1.24 | 0.02% |
| S&P/ASX 200 | 8,573.30 | 81.20 | -0.94% |
| SSE Composite Index | 4,087.86 | 5.87 | -0.14% |